Liposomal formulation of glycosphingolipids from Sphingomonas paucimobilis induces antitumour immunity in mice

VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells

(2016) Irina V. Tiper et al.   CLINICAL CANCER RESEARCH

Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset

(2016) Suryasarathi Dasgupta et al.   IMMUNOGENETICS

Coadministration of doxorubicin and etoposide loaded in camel milk phospholipids liposomes showed increased antitumor activity in a murine model

(2015) Hamzah Maswadeh et al.   International Journal of Nanomedicine

The burgeoning family of unconventional T cells

(2015) Dale I Godfrey et al.   NATURE IMMUNOLOGY

Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma

(2014) Licun Wu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Chemotherapeutic Targeting of Cancer-Induced Immunosuppressive Cells

(2014) D. Alizadeh et al.   CANCER RESEARCH

New insights into IL-12-mediated tumor suppression

(2014) S Tugues et al.   CELL DEATH AND DIFFERENTIATION

Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-β/Smad signalling pathway

(2014) Jennifer C. Bailey et al.   IMMUNOLOGY

Different subsets of natural killer T cells may vary in their roles in health and disease

(2014) Vipin Kumar et al.   IMMUNOLOGY

Combination therapy with α-galactosylceramide and a Toll-like receptor agonist exerts an augmented suppressive effect on lung tumor metastasis in a mouse model

(2014) TATSUYA ANDO et al.   ONCOLOGY REPORTS

NKT Cell Networks in the Regulation of Tumor Immunity

(2014) Faith C. Robertson et al.   Frontiers in Immunology

Immune-suppressive properties of the tumor microenvironment

(2013) Jürgen C. Becker et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

(2013) L Bracci et al.   CELL DEATH AND DIFFERENTIATION

The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration

(2013) Takashi Nakamura et al.   JOURNAL OF CONTROLLED RELEASE

Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity

(2013) Lee A Albacker et al.   NATURE MEDICINE

Invariant NKT cells increase drug-induced osteosarcoma cell death

(2012) S Fallarini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Molecular Identification of GD3 as a Suppressor of the Innate Immune Response in Ovarian Cancer

(2012) T. J. Webb et al.   CANCER RESEARCH

Raising the Roof: The Preferential Pharmacological Stimulation of Th1 and Th2 Responses Mediated by NKT Cells

(2012) James E. East et al.   MEDICINAL RESEARCH REVIEWS

Restoration of Antitumor Immunity Through Selective Inhibition of Myeloid Derived Suppressor Cells by Anticancer Therapies

(2011) L. Apetoh et al.   CURRENT MOLECULAR MEDICINE

Chemotherapy and targeted therapies for unresectable malignant mesothelioma

(2011) Ronan Joseph Kelly et al.   LUNG CANCER

CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis

(2011) Laura M. Hix et al.   PLoS One

Invariant natural killer T cells: bridging innate and adaptive immunity

(2010) Luc Van Kaer et al.   CELL AND TISSUE RESEARCH

Anthrax Lethal Toxin Impairs CD1d-Mediated Antigen Presentation by Targeting the Extracellular Signal-Related Kinase 1/2 Mitogen-Activated Protein Kinase Pathway

(2010) M. A. Khan et al.   INFECTION AND IMMUNITY

Statins Impair CD1d-Mediated Antigen Presentation through the Inhibition of Prenylation

(2009) M. A. Khan et al.   JOURNAL OF IMMUNOLOGY

Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy

(2009) Prakash Thapa et al.   VACCINE

Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma

(2008) G. J. Renukaradhya et al.   BLOOD

Clinical applications of natural killer T cell–based immunotherapy for cancer

(2008) Shinichiro Motohashi et al.   CANCER SCIENCE

Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans

(2008) Carmela De Santo et al.   JOURNAL OF CLINICAL INVESTIGATION

Liposomal glycosphingolipids activate natural killer T cell-mediated immune responses through the endosomal pathway

(2008) Joe Inoue et al.   JOURNAL OF CONTROLLED RELEASE